Tilray CEO: Alternatives in clinical cannabis are super

Tilray CEO: Alternatives in clinical cannabis are super

Tilray’s stock is up on the present time, nonetheless level-headed down 80 p.c from a February high. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon in regards to the firm’s quarterly earnings and what’s next for the trade.For access to are residing and recent video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV: n
» Subscribe to CNBC: C
» Subscribe to CNBC Traditional:

Turn to CNBC TV for essentially the most modern stock market records and analysis. From market futures to are residing heed updates CNBC is the chief in trade records worldwide.

The News with Shepard Smith is CNBC’s day-to-day records podcast offering deep, non-partisan coverage and standpoint on the day’s indispensable reports. Readily accessible to listen to by 8: 30pm ET / 5: 30pm PT day-to-day beginning September 30:

Join with CNBC News On-line
Secure essentially the most modern records: /
Observe CNBC on LinkedIn: C
Observe CNBC News on Fb: C
Observe CNBC News on Twitter: C
Observe CNBC News on Instagram: C

for/most productive-credit-cards/


Buy 1 Sleep Tincture, Get 1 FREE Sleep Well Gummies

You May Also Like

Leave a Reply